null Nadine Kronfli, MD, MPH, FRCP(C), DTM&H

Scientist, RI-MUHC, 5252 de Maisonneuve site

Infectious Diseases and Immunity in Global Health Program

Centre for Outcomes Research and Evaluation

Assistant Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Department of Medicine, Division of Infectious Diseases, MUHC



HIV • hepatitis C • COVID-19 • vulnerable populations • people in prison • migrants • implementation science • evidence-based policies

Research Focus

My research focuses on designing, deploying, and evaluating evidence-based models of care that aim to increase engagement along the HIV and hepatitis C virus care cascades for vulnerable populations, with a particular focus on incarcerated and migrant populations. During the COVID-19 pandemic, my research has expanded to include seroprevalence studies in correctional facilities and interventions to increase COVID-19 vaccine uptake among people in prison. The ultimate goal of my research is to support the development of evidence-based policies to improve population health with an emphasis on eliminating certain infectious diseases such as hepatitis C and SARS-CoV-2 among neglected populations.

Selected Publications

Click on Pubmed to see my current publications list

  • Duschene L, Dussault C, Godin A, et al. Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: a model-based cost-effectiveness analysis. Int J Drug Policy. 2021 Oct;96:103345.

  • Akiyama M, Kronfli N, Cabezas J, et al. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework. Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400.

  • Park H, Brenner B, Ibanescu RI, et al. Phylogenetic clustering among asylum seekers with new HIV diagnoses in Quebec, Canada. Viruses. 2021 Apr 1;13(4):601.

  • Kronfli N, Dussault C, Chalifoux S, et al. A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada. Int J Drug Policy. 2020 Nov;85:102921.

  • Kronfli N, Young J, Wang S, et al. Liver fibrosis in HIV-HCV co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression? Clin Infect Dis. 2021 Aug 2;73(3):468-477.